We are live on !
Find out more
Leuthold Group Portfolio holdings
AUM
$995M
Turnover
17.89%
1-Year Est. Return
44.2%
This Fund
S&P 500
This Quarter Est. Return
+18.46%
1 Year Est. Return
+44.2%
3 Year Est. Return
+125.69%
5 Year Est. Return
+177.63%
10 Year Est. Return
+694.93%
AUM
$995M
AUM Growth
+$56.4M
(+6%)
Cap. Flow
-$39.8M
Cap. Flow % of AUM
Cap. Flow %
-4%
Top 10 Holdings %
Top 10 Hldgs %
17.38%
Holding
246
New
35
Increased
28
Reduced
131
Closed
9
Avg Time Held
1.7
years
Top 10 Avg Time Held
1.4
years
Top 20 Avg Time Held
1.4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Devon Energy
DVN
|
+$8.79M |
| 2 |
iShares TIPS Bond ETF
TIP
|
+$7.31M |
| 3 |
iShares 0-5 Year TIPS Bond ETF
STIP
|
+$6.61M |
| 4 |
Elevance Health
ELV
|
+$6.42M |
| 5 |
Pfizer
PFE
|
+$5.31M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Goldman Sachs
GS
|
+$16.8M |
| 2 |
Morgan Stanley
MS
|
+$13.2M |
| 3 |
Flex
FLEX
|
+$9.38M |
| 4 |
Deutsche Bank
DB
|
+$7.91M |
| 5 |
State Street SPDR Bloomberg International Corporate Bond ETF
IBND
|
+$7.42M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 23.55% |
| 2 | Technology | 20.41% |
| 3 | Healthcare | 13.94% |
| 4 | Financials | 12.33% |
| 5 | Industrials | 7.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
51
Granite Construction
GVA
$4.73B
| $6.86M | 0.69% |
43,371
-2,208
| -5% | -$300K |
2025 Q3
3 quarters
|
|
52
Biogen
BIIB
$37B
| $6.8M | 0.68% |
31,489
-1,654
| -5% | -$316K |
2025 Q3
3 quarters
|
|
53
Gilead Sciences
GILD
$193B
| $6.7M | 0.67% |
53,031
-3,060
| -5% | -$403K |
2025 Q3
3 quarters
|
|
|
54
Elevance Health
ELV
$95.4B
| $6.69M | 0.67% |
+17,304
| New | +$6.42M |
2026 Q2
0 quarters
|
|
|
55
iShares 0-5 Year TIPS Bond ETF
STIP
$16.7B
| $6.55M | 0.66% |
+64,077
| New | +$6.61M |
2026 Q2
0 quarters
|
|
56
Valmont Industries
VMI
$8.4B
| $6.43M | 0.65% |
11,137
-483
| -4% | -$243K |
2025 Q2
4 quarters
|
|
57
iShares Core MSCI EAFE ETF
IEFA
$188B
| $6.42M | 0.65% |
66,478
-6
| -0% | -$576 |
2017 Q1
37 quarters
|
|
58
Mastercard
MA
$546B
| $6.32M | 0.64% |
12,303
-27
| -0.2% | -$13.5K |
2013 Q2
52 quarters
|
|
59
Lear
LEA
$5.76B
| $6.15M | 0.62% |
45,864
-2,358
| -5% | -$316K |
2025 Q2
4 quarters
|
|
60
Merck
MRK
$358B
| $6.14M | 0.62% |
47,803
-2,607
| -5% | -$305K |
2025 Q4
2 quarters
|
|
61
Autoliv
ALV
$8.26B
| $6.12M | 0.62% |
52,689
-2,723
| -5% | -$324K |
2025 Q2
4 quarters
|
|
62
TE Connectivity
TEL
$60.2B
| $6.11M | 0.61% |
30,305
-10,682
| -26% | -$2.28M |
2023 Q1
13 quarters
|
|
63
SLB Ltd
SLB
$78.7B
| $5.93M | 0.6% |
127,482
-7,042
| -5% | -$377K |
2025 Q4
2 quarters
|
|
64
Tenet Healthcare
THC
$21.6B
| $5.93M | 0.6% |
31,675
-1,552
| -5% | -$285K |
2023 Q3
11 quarters
|
|
65
Universal Technical Institute
UTI
$1.2B
| $5.84M | 0.59% |
136,531
-7,525
| -5% | -$289K |
2025 Q1
5 quarters
|
|
66
Oceaneering
OII
$3.91B
| $5.79M | 0.58% |
142,936
-7,236
| -5% | -$273K |
2025 Q4
2 quarters
|
|
67
Regeneron Pharmaceuticals
REGN
$82.9B
| $5.78M | 0.58% |
9,265
-515
| -5% | -$351K |
2025 Q3
3 quarters
|
|
68
PNC Financial Services
PNC
$89.5B
| $5.76M | 0.58% |
23,386
-1,286
| -5% | -$288K |
2025 Q2
4 quarters
|
|
69
Visa
V
$766B
| $5.68M | 0.57% |
16,544
-32
| -0.2% | -$10.3K |
2013 Q2
52 quarters
|
|
70
C.H. Robinson
CHRW
$16.3B
| $5.64M | 0.57% |
29,954
-1,331
| -4% | -$236K |
2025 Q4
2 quarters
|
|
71
Bristol-Myers Squibb
BMY
$126B
| $5.64M | 0.57% |
97,869
-5,364
| -5% | -$308K |
2025 Q4
2 quarters
|
|
72
Baker Hughes
BKR
$55.5B
| $5.64M | 0.57% |
101,551
-4,967
| -5% | -$314K |
2025 Q4
2 quarters
|
|
73
Covista Inc
CVSA
$4.46B
| $5.62M | 0.57% |
45,106
-2,456
| -5% | -$296K |
2024 Q4
6 quarters
|
|
74
US Bancorp
USB
$92.8B
| $5.57M | 0.56% |
92,155
-5,193
| -5% | -$291K |
2025 Q2
4 quarters
|
|
75
United Therapeutics
UTHR
$25.2B
| $5.52M | 0.55% |
10,184
-552
| -5% | -$311K |
2025 Q3
3 quarters
|
|
Similar funds
PAI
Leuthold Group's Q2 2026 Portfolio in Review
As of Q2 2026, Leuthold Group held 246 positions worth $995M, up 6% from $939M the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Leuthold Group withdrew a net $39.8M in Q2 2026, closing 9 positions and reducing 131 holdings. Its most notable exit was Sanofi, an estimated $4.63M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 24% of assets, down from 25% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Leuthold Group opened a new position in iShares TIPS Bond ETF worth $7.24M.
- Leuthold Group's largest Q2 2026 buy was iShares TIPS Bond ETF: 66,153 shares worth $7.24M.
- Leuthold Group added most to Devon Energy in Q2 2026, an estimated $8.79M increase.
- Leuthold Group's biggest Q2 2026 reduction was Goldman Sachs, cutting an estimated $16.8M.
- Leuthold Group fully exited Sanofi in Q2 2026, selling an estimated $4.63M.
- Leuthold Group's ten largest holdings make up 17% of its $995M portfolio in Q2 2026.
- Leuthold Group opened 35 new positions and closed 9 in Q2 2026.
- Leuthold Group's portfolio value rose 6% quarter-over-quarter to $995M.
Based on Leuthold Group's 13F filing for Q2 2026, filed 4 Aug 2026.